chemXplore tracks 1 project in Cyprus, of which one is active.
Of the active ones, 1 new construction.
Main EPC and drilling contracts signed; project targets >3 TCF resources and up to 500 mmscf/d plateau, start-up H1 2028, gas to be processed in Egypt and liquefied at Damietta.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.
Valued at USD $500–$750M, the deal covers project management, engineering, procurement and installation support, executed from hubs in Houston, Perth, London and Kuala Lumpur.
Q2 profit USD 786m; strong oil and gas prices plus higher refining and petrochemical margins offset fuel price caps and operational outages.
35% non-operated stake in Cyprus Block 12 (Aphrodite); produced gas to be sold to EGAS; completion expected early 2027, subject to approvals.
Net sales +5.2% organic H1; recurring EBIT margin 18.1%; closed Xella and Cementos Pacasmayo; FY2026 guidance raised to ~5% sales and ~10% recurring EBIT growth.
Double-digit underlying production growth, new JV and project FIDs, entry into critical minerals, and a larger share buyback with slightly higher 2026 production guidance.
Final Investment Decision for Cronos targets first Cypriot gas in 2028; field holds >3 Tcf GIIP and will route gas via Egypt’s Zohr and Damietta for LNG exports.
Cyprus' first gas field will send about 2.8 Mtpa LNG to Europe via Egypt's Damietta terminal; start-up expected 2028 and half the output will be marketed to Europe.
